Meiji Holdings Management
Management criteria checks 4/4
Meiji Holdings' CEO is Kazuo Kawamura, appointed in Jun 2018, has a tenure of 6.17 years. total yearly compensation is ¥136.00M, comprised of 58.8% salary and 41.2% bonuses, including company stock and options. directly owns 0.042% of the company’s shares, worth ¥395.68M. The average tenure of the management team and the board of directors is 6.2 years and 6.7 years respectively.
Key information
Kazuo Kawamura
Chief executive officer
JP¥136.0m
Total compensation
| CEO salary percentage | 58.8% |
| CEO tenure | 6.2yrs |
| CEO ownership | 0.04% |
| Management average tenure | 6.2yrs |
| Board average tenure | 6.7yrs |
Recent management updates
Recent updates
Meiji Holdings Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Aug 13
Does Meiji Holdings (TSE:2269) Have A Healthy Balance Sheet?
Aug 03Investors Could Be Concerned With Meiji Holdings' (TSE:2269) Returns On Capital
Jul 03Is There An Opportunity With Meiji Holdings Co., Ltd.'s (TSE:2269) 22% Undervaluation?
Jun 12Why Meiji Holdings' (TSE:2269) Shaky Earnings Are Just The Beginning Of Its Problems
May 22Meiji Holdings (TSE:2269) Has A Pretty Healthy Balance Sheet
May 01Meiji Holdings Co., Ltd.'s (TSE:2269) Shares May Have Run Too Fast Too Soon
Apr 11Meiji Holdings (TSE:2269) Will Be Hoping To Turn Its Returns On Capital Around
Mar 19Meiji Holdings Co., Ltd.'s (TSE:2269) Intrinsic Value Is Potentially 31% Above Its Share Price
Feb 29CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | JP¥53b |
| Mar 31 2024 | JP¥136m | JP¥80m | JP¥51b |
| Dec 31 2023 | n/a | n/a | JP¥67b |
| Sep 30 2023 | n/a | n/a | JP¥64b |
| Jun 30 2023 | n/a | n/a | JP¥65b |
| Mar 31 2023 | JP¥146m | JP¥77m | JP¥69b |
| Dec 31 2022 | n/a | n/a | JP¥79b |
| Sep 30 2022 | n/a | n/a | JP¥84b |
| Jun 30 2022 | n/a | n/a | JP¥91b |
| Mar 31 2022 | JP¥143m | JP¥71m | JP¥87b |
| Dec 31 2021 | n/a | n/a | JP¥72b |
| Sep 30 2021 | n/a | n/a | JP¥74b |
| Jun 30 2021 | n/a | n/a | JP¥65b |
| Mar 31 2021 | JP¥144m | JP¥70m | JP¥66b |
| Dec 31 2020 | n/a | n/a | JP¥64b |
| Sep 30 2020 | n/a | n/a | JP¥64b |
| Jun 30 2020 | n/a | n/a | JP¥66b |
| Mar 31 2020 | JP¥18m | n/a | JP¥67b |
| Dec 31 2019 | n/a | n/a | JP¥52b |
| Sep 30 2019 | n/a | n/a | JP¥55b |
| Jun 30 2019 | n/a | n/a | JP¥59b |
| Mar 31 2019 | JP¥135m | JP¥67m | JP¥62b |
Compensation vs Market: Kazuo's total compensation ($USD921.81K) is about average for companies of similar size in the JP market ($USD1.13M).
Compensation vs Earnings: Kazuo's compensation has been consistent with company performance over the past year.
CEO
Kazuo Kawamura (71 yo)
6.2yrs
Tenure
JP¥136,000,000
Compensation
Mr. Kazuo Kawamura has been Director at Global Dairy Platform. Mr. Kawamura has been President and Chief Executive Officer of Meiji Holdings Co., Ltd. since June 2018 and June 2020 respectively and served...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 6.2yrs | JP¥136.00m | 0.042% ¥ 417.0m | |
| COO of Food Segment | 4.2yrs | JP¥109.00m | 0.016% ¥ 159.4m | |
| CFO, Director | 9.2yrs | no data | 0.026% ¥ 264.4m | |
| Senior Managing Executive Officer | 10.2yrs | no data | 0.0096% ¥ 96.1m | |
| Head of Group HR Strategy & Executive Officer | no data | no data | no data | |
| COO of Pharmaceutical Segment | 4.2yrs | no data | 0.016% ¥ 155.6m | |
| Head of Sustainable Management Department & Executive Officer | no data | no data | no data |
6.2yrs
Average Tenure
68.5yo
Average Age
Experienced Management: 2269's management team is seasoned and experienced (6.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President | 12.2yrs | JP¥136.00m | 0.042% ¥ 417.0m | |
| COO of Food Segment | 6.2yrs | JP¥109.00m | 0.016% ¥ 159.4m | |
| CFO, Director | 9.2yrs | no data | 0.026% ¥ 264.4m | |
| Senior Managing Executive Officer | 10.2yrs | no data | 0.0096% ¥ 96.1m | |
| COO of Pharmaceutical Segment | 10.2yrs | no data | 0.016% ¥ 155.6m | |
| Independent Outside Director | 3.2yrs | no data | 0.00076% ¥ 7.6m | |
| Independent Outside Director | 2.2yrs | no data | 0.00020% ¥ 2.0m | |
| Independent Outside Audit & Supervisory Board Member | 11.2yrs | no data | no data | |
| Independent Outside Audit & Supervisory Board Member | 7.2yrs | no data | 0.0033% ¥ 32.9m | |
| Independent Outside Director | 6.2yrs | no data | 0.00069% ¥ 6.9m | |
| Independent Outside Director | 3.2yrs | no data | 0.00038% ¥ 3.8m | |
| Audit & Supervisory Board Member | 3.2yrs | no data | 0.0030% ¥ 30.0m |
6.7yrs
Average Tenure
67yo
Average Age
Experienced Board: 2269's board of directors are considered experienced (6.7 years average tenure).